Oxford–AstraZeneca COVID-19 vaccine

Vaccine against COVID-19

Oxford–AstraZeneca COVID-19 vaccine ▸ Facts ▸ Comments ▸ News ▸ Videos

The Oxford–AstraZeneca COVID-19 vaccine, codenamed AZD1222, and sold under the brand name Covishield and Vaxzevria among others, is a viral vector vaccine for COVID-19 developed by Oxford University and AstraZeneca given by intramuscular injection, using as a vector the modified chimpanzee adenovirus ChAdOx1. An analysis published on 19 February 2021 showed an efficacy of 76.0% at preventing symptomatic COVID-19 beginning at 22 days following the first dose, increasing to 81.3% when the second dose is given 12 weeks or more after the first.

0 shares	Share Tweet Save Post Send



Vaccines to last for 2 days, expect GoI to send them: Odisha COVID Vaccination In-Charge COVID-19 Vaccination In-Charge in Odisha, Bijay Panigrahi, said that they expect to receive more vaccines within two days from the Government of India. "Vaccine program is going on smoothly in the.. Credit: ANI Duration: 01:35Published 13 hours ago

Watch: Special vehicle carrying COVID-19 vaccines breaks down in Patna Amid scarcity of COVID-19 vaccines in some states, a special transport special transport vehicle carrying COVID-19 vaccine, (Covishield) broke down in Patna on April 09. Pharmacist Mukesh Kumar, who.. Credit: ANI Duration: 01:00Published 21 hours ago

Odisha: After vaccine shortage reports, long queues outside vaccination centre People line up outside the Covid-19 vaccination centre in Bhubaneswar on Friday. Some people standing in the queue claimed that there is a shortage of vaccine at the Centre. However, Dr Laxmidhar.. Credit: HT Digital Content Duration: 03:35Published 22 hours ago

Seychelles President thanks India for 'precious' donation of COVID vaccines President of Seychelles, Wavel Ramkalawan during a virtual meet with Prime Minister Narendra Modi thanked him for solidarity and contribution in fight against COVID-19 by donating 50,000 doses of.. Credit: ANI Duration: 01:50Published 2 days ago

‘Stock will last for 2 days:’ Odisha Health minister on Covid vaccine shortage Odisha Health Minister, Naba Kishore Das has written to Union Health Minister Dr Harsh Vardhan requesting supply of at least 10 days stock (or 25 lakh doses) of Covishield vaccine to the state.. Credit: HT Digital Content Duration: 01:36Published 2 days ago

Covid: Centre explains 5 steps discussed with States to curb virus spread Centre on Saturday spoke on the five steps discussed with the States that have high number of Covid-19 cases. Health Secretary Rajesh Bhushan said that Centre discussed the steps with States to curb.. Credit: HT Digital Content Duration: 09:52Published 2 weeks ago

India gifts one lakh doses of COVID-19 vaccine to Nepal Army As a mark of friendship and strong ties between New Delhi and Kathmandu, India gifted one lakh doses of COVID-19 vaccines to the Nepal Army on March 28. The nine packages of Covishield vaccines,.. Credit: ANI Duration: 01:23Published 2 weeks ago

India-made vaccine to be dispatched for Denmark A consignment of Covishield vaccine, by Serum Institute of India, to be dispatched from Mumbai's Chhatrapati Shivaji Maharaj International Airport to Denmark's Copenhagen as part of the 'Vaccine.. Credit: ANI Duration: 01:25Published 2 weeks ago

Covid: Centre reassures Covishield’s safety, explains how to stop virus mutation NITI Aayog Member (Health) V K Paul said there is adequate supplies of vaccines for inoculating those aged 45 and above. "We have seamless connection with states. There is no inadequacy of vaccine.. Credit: HT Digital Content Duration: 09:51Published 2 weeks ago

COVID Vaccine will be available for everyone above 45 years of age from April 1: Javadekar Union Minister Prakash Javadekar during a press conference on March 23 informed that from April1, vaccine will be available for everyone above 45 years and urged them to immediately register and get.. Credit: ANI Duration: 02:12Published 3 weeks ago

Study Finds AstraZeneca Vaccine to Be 79 Percent Efficient Against Symptomatic COVID-19 On Monday, results were announced from a late-stage study on AstraZeneca’s COVID-19 vaccine, AZD1222 Credit: Cover Video STUDIO Duration: 01:10Published 3 weeks ago

Prisoners of Indore Central Jail get vaccinated Several prisoners of Central Jail in Indore were given the first shot of COVID-19 vaccine. "300 doses of Covishield have been received. Some prisoners have been vaccinated and some are yet to get the.. Credit: ANI Duration: 02:08Published 3 weeks ago

Johnson to receive Covid vaccination ‘very shortly’ Prime Minister Boris Johnson has revealed he will receive his coronavirus vaccination “very shortly”. He added the jab “will certainly be Oxford-AstraZeneca”. Report by Avagninag. Like us on.. Credit: ODN Duration: 00:23Published 3 weeks ago

Johnson to received Covid vaccination ‘very shortly’ Prime Minister Boris Johnson has revealed he will receive his coronavirus vaccination “very shortly”. He added the jab “will certainly be Oxford-AstraZeneca”. Report by Avagninag. Like us on.. Credit: ODN Duration: 00:23Published 3 weeks ago

Germany, France, Italy and Spain pause AstraZeneca Covid-19 vaccine, know why\| Oneindia News Germany, France and Italy have suspended use of the Oxford-AstraZeneca coronavirus vaccine as EU regulators investigate reports some people developed blood clots after having the jab, depite World.. Credit: Oneindia Duration: 01:21Published on March 16, 2021

Covid vaccine explained: Covishield? Covaxin? Do's and Don'ts \| Oneindia News The second phase of India's covid vaccine drive is receiving an enthusiastic response. However, if you are hesitant about the vaccine since you are on medication or recently recovered from some serious.. Credit: Oneindia Duration: 03:13Published on March 5, 2021

CM Pramod Sawant administers 1st dose of Covishield vaccine Goa Chief Minister Pramod Sawant took his first dose of the COVID-19 vaccine on March 03. Pramod Sawant took the Covishield jab at PHC Sankhali. CM further urged people to come forward and get.. Credit: ANI Duration: 02:18Published on March 3, 2021

Vaccine Maitri: 'Made in India' COVID vaccines arrive in Saint Lucia, Saint Vincent and the Grenadines India provided COVID-19 vaccines to Saint Lucia on March 01. 'Made in India' vaccines was received by the Prime Minister Allen Chastanet of Saint Lucia. India provided 25,000 doses of coronavirus.. Credit: ANI Duration: 02:21Published on March 1, 2021

Covid vaccine: How to register, where to go, what you need \| All key details Phase 2 of India's Covid-19 vaccination drive was launched in high-profile manner on March 1 with Prime Minister Narendra Modi becoming one of the first beneficiaries. The second phase of the programme.. Credit: HT Digital Content Duration: 04:31Published on March 1, 2021

Guatemala President thanks India for donating 2 lakh vaccine doses Guatemala President Alejandro Giammattei thanked Prime Minister Narendra Modi and External Affairs Minister S Jaishankar for donating 2,00,000 doses of Covishield vaccines. President Alejandro.. Credit: ANIPublished on February 27, 2021

You Might Like

India hands over consignment of a lakh 'Made-in-India' Covishield doses IndiaTimes - Published 2 weeks ago
Covishield, Covaxin effective against UK, Brazillian variants; work against South African strain on: Govt Both Covishield and Covaxin vaccines are effective against the UK and the Brazillian variants of coronavirus, while the work against the South African strain was on at several laboratories, the Centre.. IndiaTimes - Published 2 weeks ago
No risk of blood clotting from Covishield, says Niti’s Paul There is no risk of thrombosis or blood clotting due to use of Covishield, Niti Aayog member-health Dr V K Paul said on Wednesday and urged people to get vaccinated without any fear. This comes in the.. IndiaTimes - Published 2 weeks ago

India delays exports of Covishield amid Covid surge; Centre allays safety concerns IndiaTimes - Published 2 weeks ago
Govt raises gap between Covishield shots to 4-8 weeks The health ministry on Monday revised the interval between two doses of the Covishield vaccine to 4-8 weeks, from the existing 4-6 weeks, after evidence showed higher efficacy following a longer gap.. IndiaTimes - Published 3 weeks ago
Second dose of Covishield vaccine to be administered in 6-8 weeks now instead of 4 Notably, the new guidelines are only applicable to the Covishield vaccine and not the Covaxin coronavirus vaccine. DNA - Published 3 weeks ago

Increase gap between two doses of Covishield to 6-8 weeks, Centre tells states The Centre on Monday said that the gap between the first and second doses of the AstraZeneca-Oxford University's Covishield vaccine should be increased to 6-8 weeks from the current 28 days.The Centre.. IndiaTimes - Published 3 weeks ago
Govt: No concerns over Covishield yet, drive to continue IndiaTimes - Published 3 weeks ago
Why Covishield is ‘safe’ despite the blood clot scare in Europe Cases of blood clots among vaccinated people are no common than in general population, say experts IndiaTimes - Published 3 weeks ago
Govt orders 10cr more doses of Covishield IndiaTimes - Published on March 16, 2021

Is the blood-clot scare in Europe over Covishield really justified? Serum Institute’s Covishield is India’s main Covid vaccine. In the West, it is known as the ‘Oxford’ or ‘AstraZeneca’ vaccine. Over the past few days, 11 European countries,.. IndiaTimes - Published on March 16, 2021
Ireland, Netherlands suspend AstraZeneca Covid-19 vaccine: Highlights Ireland and The Netherlands became the latest countries to suspend the use of the AstraZeneca/Oxford University vaccine for their Covid-19 immunisation programme. The Indian version of the vaccine.. IndiaTimes - Published on March 15, 2021
Covaxin out of clinical trial mode, granted restricted emergency use authorisation The Centre on Thursday said Bharat Biotech's indigenously developed Covaxin is out of the "clinical trial mode" and that it has now been granted the regular restricted emergency use authorisation just.. IndiaTimes - Published on March 11, 2021	COVID-19: Centenarian vaccinated with Covishield at Delhi hospital The beneficiary was given the Serum Institute of India's (SII) 'Covishield' vaccine which did not cause him any side effect. DNA - Published on March 6, 2021
Covid-19 recovered people showing faster antibody response to Covishield vaccine: Study IndiaTimes - Published on March 3, 2021	President Ghani lauds PM Modi as Afghanistan begins COVID-19 vaccination using India-made vaccine India had gifted 500,000 doses of COVISHIELD vaccines earlier this month to Afghanistan. DNA - Published on February 23, 2021
Adar Poonawalla urges countries to be patient, says Serum directed to prioritise India needs Adar Poonawalla, CEO of vaccine major Serum Institute of India (SII), on Sunday urged other countries to be patient as they wait for the supplies of Covid-19 vaccine, Covishield, as the company has.. IndiaTimes - Published on February 21, 2021	Vaccinator held for ‘stealing’ vials of Covishield from Maha hosp IndiaTimes - Published on February 20, 2021
Covid-19: Can our vaccine fight new strains? India to test The efficacy of the two Indian vaccines currently in use — Covishield and Covaxin — is likely to be tested against the Brazil and South Africa variants soon, scientists have said. The Indian.. IndiaTimes - Published on February 17, 2021	India dispatches Covid-19 vaccines to Barbados, Dominica India had earlier provided Barbados with Covishield vaccines, for which the country's Prime Minister Mia Mottley has expressed her gratitude to the Indian government and the people for the "most.. IndiaTimes - Published on February 8, 2021Also reported by •DNA
South Africa halts rollout of AstraZeneca COVID jab due to 'limited protection' South Africa is suspending its rollout of the Oxford/AstraZeneca coronavirus vaccine after finding it offers limited protection against mild disease caused by the COVID-19 variant discovered there. Sky News - Published on February 7, 2021	India approves 100,000 Covishield doses for China ally Cambodia IndiaTimes - Published on February 5, 2021
Govt places second purchase order with Serum Institute for 1 crore doses of Covishield IndiaTimes - Published on February 3, 2021	Supply order for Covishield vaccine was placed after drug regulator approved it: Govt IndiaTimes - Published on February 2, 2021
India-made Covishield part of Pakistan jab drive under vaccine alliance India’s vaccine diplomacy took further wing with 1 lakh anti-Covid shots being sent to Oman, a close partner in the Gulf, after having supplied the jabs to immediate neighbours. Later this week,.. IndiaTimes - Published on January 31, 2021	Covaxin: With focus on globalisation, Bharat Biotech files for emergency use approval in Philippines New Delhi has gifted India-made Covishield vaccine of Oxford-AstraZeneca made by Serum Institute of India to 10 countries. DNA - Published on January 31, 2021
Pune civil court rejects plea to restrain SII from using 'Covishield' trademark Cutis Biotech claimed it was using the trademark of 'Covishield' before the SII and filed a suit in the civil court to restrain the SII from using it. DNA - Published on January 31, 2021	Relief for SII as court rejects trademark-violation plea over 'Covishield' IndiaTimes - Published on January 30, 2021
No adverse reactions so far following vaccination: Sri Lanka Sri Lanka on Friday launched its national coronavirus immunisation campaign by administering the first shots to frontline health workers, soldiers and security personnel, a day after India gifted.. IndiaTimes - Published on January 30, 2021	Those on blood thinners can receive vaccine, says ICMR Fact-sheets of both Covaxin and Covishield will be revised soon so that people on blood thinners like aspirin and clopidogrel can receive the vaccines, while those on anticoagulants may also take the.. IndiaTimes - Published on January 28, 2021
India to gift 5 lakh doses of Covishield vaccine to Sri Lanka tomorrow This gift of Covid-19 vaccines to Sri Lanka is a part of India's "Vaccine Maitri" initiative under which India has gifted vaccines to seven other countries in the region. The consignment, which will be.. IndiaTimes - Published on January 27, 2021	India sends 2 million doses of Covishield each to Brazil & Morocco IndiaTimes - Published on January 22, 2021
India to send SII's COVID-19 vaccine 'Covishield' to Myanmar, Seychelles, Mauritius The Ministry of External Affairs had announced a vaccine rollout for Bhutan, Maldives, Bangladesh, Nepal, Myanmar and Seychelles from Wednesday. DNA - Published on January 22, 2021	5 die in fire at Serum plant, Covishield production unaffected IndiaTimes - Published on January 21, 2021
Adar Poonawalla reassures Covishield production won't be affected, tweets 'no lives lost' in SII fire A major fire broke out at a building inside Terminal Gate 1 of the Serum Institute of India (SII) in Maharashtra's Pune on Thursday afternoon. DNA - Published on January 21, 2021	India sends 30 lakh dosages of COVID-19 vaccine Covishield to Nepal, Bangladesh The consignment arrived at Mumbai's Chhatrapati Shivaji Maharaj International Airport in the wee hours of Thursday. DNA - Published on January 21, 2021
India dispatches first consignment of 100,000 Covishield vaccines to Maldives With this, Maldives (along with Bhutan) has become the first recipient of India's gift of the Covishield vaccines, manufactured by the Serum Institute of India (SII). Earlier on Wednesday, India sent a.. IndiaTimes - Published on January 20, 2021	India begins exporting COVID-19 vaccines, 1.5 lakh Covishield doses dispatched to Bhutan The consignment containing 1.5 lakh doses of Covishield is scheduled to reach Bhutan's capital Thimphu on Wednesday at around noon. DNA - Published on January 20, 2021
Covid-19: India dispatches 1.5 lakh doses of Covishield vaccine as gift to Bhutan IndiaTimes - Published on January 20, 2021	Cambodian PM Hun Sen seeks India's assistance for Covid-19 vaccine The Cambodian Prime Minister Hun Sen on Monday requested the Indian government to provide the Covid-19 vaccine during his meeting with the new Indian ambassador to Cambodia Devyani Uttamkhobragade,.. IndiaTimes - Published on January 19, 2021
Covishield not to be taken by people severely allergic to any of its ingredients: Serum Institute People who are severely allergic to any ingredient of Covid-19 vaccine 'Covishield' are advised not to take it, Serum Institute of India said. According to the fact sheet for the vaccine recipient by.. IndiaTimes - Published on January 19, 2021	Both Covishield and Covaxin vaccines have 6-months shelf life: Health ministry IndiaTimes - Published on January 18, 2021
Covishield jab takes 4 minutes, Covaxin double that time IndiaTimes - Published on January 18, 2021	India may get four more COVID-19 vaccines soon, SII says work in progress According to Suresh Jadhav, Executive Director of the Serum Institute, work is progressing rapidly on four more vaccines in addition to Covishield. DNA - Published on January 18, 2021
COVID-19: Resident doctors of RML hospital show reservations about Covaxin, want Covishield The most-awaited nationwide vaccination drive against the novel coronavirus infection in India commenced on Saturday. DNA - Published on January 16, 2021	World's largest COVID vaccination drive underway: Know all about Covishield and Covaxin The world's largest vaccination programme in India will take place in all the states and union territories across the length and breadth of the countr DNA - Published on January 16, 2021
Resident docs in RML Hospital want Covishield, expresses 'bit apprehension' about Covaxin Resident doctors of Delhi's Ram Manohar Lohia Hospital have requested the medical superintendent to vaccinate them with Covishield. "The residents are a bit apprehensive about the lack of complete.. IndiaTimes - Published on January 16, 2021	Vaccine drive accelerates, doses reach far corners of India While SII moved about 56 lakh doses of Covishield to 13 cities, Hyderabad-based Bharat Biotech said it had successfully transported the indigenous Covaxin, developed in collaboration with the ICMR and.. IndiaTimes - Published on January 13, 2021
After Covishield, first batch of Bharat Biotech's Covaxin arrives in Delhi Both Covishield and Covaxin, the two COVID-19 vaccines, have received Emergency Use Authorisation from the government. DNA - Published on January 13, 2021	Covid vaccine recipients may not be able to pick & choose Even as the government plans to roll out the Covid vaccination drive with Oxford-AstraZeneca’s Covishield and Bharat Biotech’s Covaxin, recipients may not have an option to choose which one they.. IndiaTimes - Published on January 12, 2021

Oxford–AstraZeneca COVID-19 vaccine

Vaccine against COVID-19

Oxford–AstraZeneca COVID-19 vaccine ▸ Facts ▸ Comments ▸ News ▸ Videos

You Might Like

India hands over consignment of a lakh 'Made-in-India' Covishield doses

Covishield, Covaxin effective against UK, Brazillian variants; work against South African strain on: Govt

No risk of blood clotting from Covishield, says Niti’s Paul

India delays exports of Covishield amid Covid surge; Centre allays safety concerns

Govt raises gap between Covishield shots to 4-8 weeks

Second dose of Covishield vaccine to be administered in 6-8 weeks now instead of 4

Increase gap between two doses of Covishield to 6-8 weeks, Centre tells states

Govt: No concerns over Covishield yet, drive to continue

Why Covishield is ‘safe’ despite the blood clot scare in Europe

Govt orders 10cr more doses of Covishield

Is the blood-clot scare in Europe over Covishield really justified?

Ireland, Netherlands suspend AstraZeneca Covid-19 vaccine: Highlights

Covaxin out of clinical trial mode, granted restricted emergency use authorisation

COVID-19: Centenarian vaccinated with Covishield at Delhi hospital

Covid-19 recovered people showing faster antibody response to Covishield vaccine: Study

President Ghani lauds PM Modi as Afghanistan begins COVID-19 vaccination using India-made vaccine

Adar Poonawalla urges countries to be patient, says Serum directed to prioritise India needs

Vaccinator held for ‘stealing’ vials of Covishield from Maha hosp

Covid-19: Can our vaccine fight new strains? India to test

India dispatches Covid-19 vaccines to Barbados, Dominica

South Africa halts rollout of AstraZeneca COVID jab due to 'limited protection'

India approves 100,000 Covishield doses for China ally Cambodia

Govt places second purchase order with Serum Institute for 1 crore doses of Covishield

Supply order for Covishield vaccine was placed after drug regulator approved it: Govt

India-made Covishield part of Pakistan jab drive under vaccine alliance

Covaxin: With focus on globalisation, Bharat Biotech files for emergency use approval in Philippines

Pune civil court rejects plea to restrain SII from using 'Covishield' trademark

Relief for SII as court rejects trademark-violation plea over 'Covishield'

No adverse reactions so far following vaccination: Sri Lanka

Those on blood thinners can receive vaccine, says ICMR

India to gift 5 lakh doses of Covishield vaccine to Sri Lanka tomorrow

India sends 2 million doses of Covishield each to Brazil & Morocco

India to send SII's COVID-19 vaccine 'Covishield' to Myanmar, Seychelles, Mauritius

5 die in fire at Serum plant, Covishield production unaffected

Adar Poonawalla reassures Covishield production won't be affected, tweets 'no lives lost' in SII fire

India sends 30 lakh dosages of COVID-19 vaccine Covishield to Nepal, Bangladesh

India dispatches first consignment of 100,000 Covishield vaccines to Maldives

India begins exporting COVID-19 vaccines, 1.5 lakh Covishield doses dispatched to Bhutan

Covid-19: India dispatches 1.5 lakh doses of Covishield vaccine as gift to Bhutan

Cambodian PM Hun Sen seeks India's assistance for Covid-19 vaccine

Covishield not to be taken by people severely allergic to any of its ingredients: Serum Institute

Both Covishield and Covaxin vaccines have 6-months shelf life: Health ministry

Covishield jab takes 4 minutes, Covaxin double that time

India may get four more COVID-19 vaccines soon, SII says work in progress

COVID-19: Resident doctors of RML hospital show reservations about Covaxin, want Covishield

World's largest COVID vaccination drive underway: Know all about Covishield and Covaxin

Resident docs in RML Hospital want Covishield, expresses 'bit apprehension' about Covaxin

Vaccine drive accelerates, doses reach far corners of India

After Covishield, first batch of Bharat Biotech's Covaxin arrives in Delhi

Covid vaccine recipients may not be able to pick & choose